| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +268.0% |
| Cost of Revenue | $1.3M | +6200.0% |
| R&D Expense | $84.3M | -7.6% |
| SG&A Expense | $83.4M | +21.3% |
| Operating Income | -$171.8M | -7.6% |
| Interest Expense | $13.3M | +62.1% |
| Net Income | -$179.1M | -8.0% |
| EPS (Basic) | -$6.15 | -3.9% |
| EPS (Diluted) | -$6.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.2M | -66.3% |
| Accounts Receivable | $71K | -71.4% |
| Inventory | $2.0M | +0.3% |
| Current Assets | $72.1M | -64.4% |
| Total Assets | $73.7M | -64.2% |
| Current Liabilities | $27.3M | -17.1% |
| Long-term Debt | $100.6M | +8.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$155.0M | -14.5% |
| Capital Expenditures | $20K | -85.6% |
| Investing Cash Flow | -$20K | +85.6% |
| Financing Cash Flow | $26.5M | -72.4% |
| Free Cash Flow | -$155.0M | -14.4% |
| -3.9% |
| Total Liabilities |
| $130.2M |
| +0.9% |
| Stockholders' Equity | -$56.5M | -173.6% |